An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Abstract Migraine headache is a common, chronic, debilitating disease with a complex etiology. Current therapy for migraine headache comprises either treatments targeting acute migraine pain or prophylactic therapy aimed at increasing the length of time between migraine episodes. Recent evidence sug...

Full description

Bibliographic Details
Main Authors: Ivan Urits, Gavin Clark, Daniel An, Bredan Wesp, Rebecca Zhou, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Anh L. Ngo, Alan D. Kaye, Rachel J. Kaye, Elyse M. Cornett, Omar Viswanath
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-03-01
Series:Pain and Therapy
Subjects:
Chronic pain
CGRP
Fremanezumab
Headache
Migraine
Monoclonal antibody
Online Access:https://doi.org/10.1007/s40122-020-00159-3

Internet

https://doi.org/10.1007/s40122-020-00159-3

Similar Items